AbbVie (NYSE: ABBV) today announced topline results from the Phase 3 EPCORE® DLBCL-1 trial evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, compared to ...

Genmab A/S (Nasdaq: GMAB) today announced topline results from the Phase 3 EPCORE DLBCL-1 trial evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, which ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The development process for the ...

The following is a summary of a story on the Student Experience website. Seth and Susan Lee’s son, Jacob, is a Duke undergrad set to graduate in May. Jacob has lived with life-threatening nut and seed ...

Sempresto, Inc., a medical device company pioneering smartphone integrated rescue drug delivery, today announced the acquisition of Alerje’s mobile device integrated auto-injector platform, including ...

A Prescription Drug User Fee Act target date of July 26, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application ...

The LA Auto Show has several special display areas featuring exotics, customs, race cars and more. The show runs through Nov. 30 at the Los Angeles Convention Center. Carlo Figueroa stood in front of ...

Swiss machine maker lays off staff after US tariffs Pfiffner already struggling due to car industry woes Weak German, Chinese demand hits manufacturers UTZENSTORF, Switzerland, Nov 14 (Reuters) - ...

A new mold concept developed by Zahoransky is engineered to accelerate the mass production of housings for insulin pens and auto injectors in a space- and energy-efficient manner. The Z.Sonic turn ...

Posts from this topic will be added to your daily email digest and your homepage feed. GM CEO Mary Barra says consumers should expect the full phase out of CarPlay and Android Auto over the next few ...

The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and cluster headaches in adults, Amneal Pharmaceuticals announced Thursday. The ...

Auto-injector specialist Ypsomed is hopping on the U.S. manufacturing bandwagon, investing 200 million Swiss francs ($248 million) to build a plant in Holly Springs, North Carolina. It will be the ...